Therefore, targeting CXCR2 to inhibit neutrophil infiltration and activation, thereby protecting liver resident non-immune cells, raises a potential therapeutic target to support the host response to infection, reducing hepatotoxicity [19, 73]. This evidence concerns the gene CXCR2 and infection.